Osmotic Piston Drug Delivery for Precise Fixed-Dose Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Poor medication adherence and drug overdoses, particularly among older adults on multiple medications, lead to worsened health outcomes and increased mortality, while existing drug delivery systems lack comprehensive strategies for clinical efficacy, toxicity management, and personalized dosing.

Innovation Solution

An implantable device comprising modules such as a permeability module, sensor module, drug chamber, valve module, and electronic module, which uses osmotic pressure to control drug release, monitors physiological parameters, and adjusts dosing through a communication network and AI system for precise drug delivery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If traditional drug delivery systems are used, then ease of operation is maintained, but manufacturing precision and dosing accuracy deteriorate due to lack of control mechanisms

Engineering Contradiction:
Improvedosing accuracyVSAvoidsystem complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The device is divided into distinct functional modules: osmotic chamber, drug chamber, piston, valve module, and sensor module. Each module performs a specific function, allowing independent optimization and assembly. The segmentation enables precise control of drug delivery while maintaining manageable system complexity through modular design.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Sensor modules continuously monitor physiological parameters (glucose levels, pH, temperature) and drug delivery status, providing real-time feedback to the control system. This feedback loop enables dynamic adjustment of dosing parameters to achieve precise manufacturing precision and dosing accuracy while maintaining ease of operation through automated control.

Inventive Principle:
Principle #23Feedback

2Manufacturing precision

If fixed dose delivery is implemented, then manufacturing precision improves, but adaptability deteriorates due to rigid dosing protocols

Engineering Contradiction:
Improvedose consistencyVSAvoiddosing flexibility
Core Design Contradiction:
Manufacturing precisionVSAdaptability or versatility

Solution Approach 1:

The device transitions from static fixed-dose delivery to dynamic adaptive dosing. The control system adjusts delivery parameters in real-time based on sensor feedback and AI predictions, enabling the system to maintain dose consistency through controlled variability. This allows the device to adapt to changing physiological conditions while preserving manufacturing precision through automated regulation.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system dynamically changes delivery parameters (flow rate, timing, duration) based on real-time physiological data and AI predictions. This parameter adaptation enables the device to maintain precise dosing control while responding to individual patient needs, effectively resolving the contradiction between dose consistency and dosing flexibility.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If comprehensive monitoring and AI prediction systems are added, then reliability improves, but device complexity increases

Engineering Contradiction:
Improvesafety monitoringVSAvoidsystem architecture
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Sensor modules serve multiple functions: monitoring physiological parameters, detecting device anomalies, providing feedback for control adjustments, and generating data for AI predictions. This multi-functionality reduces the need for separate dedicated components, thereby improving reliability through comprehensive monitoring while minimizing increases in device complexity through functional integration.

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Ease of operation

If osmotic pressure mechanisms are used, then ease of operation improves through passive delivery, but manufacturing precision deteriorates due to lack of active control

Engineering Contradiction:
Improvepassive deliveryVSAvoiddose control
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The piston acts as an intermediary between the passive osmotic pressure mechanism and the active control system. Osmotic pressure provides the driving force for drug delivery (ease of operation), while the piston's position and movement are precisely controlled by the valve module and sensor feedback (manufacturing precision). This intermediary mechanism reconciles passive delivery with active control.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device ensures precise and consistent drug delivery with minimal dose variation, monitors device anomalies, and predicts body responses to adjust dosing, thereby improving medication adherence and reducing overdose risks.

Implementation Method 1

body fluid may enter through the semipermeable membrane, which may generate osmotic pressure that drives the movement of the compressible piston

Methodology Applied
Scientific EffectOsmotic pressure: Osmotic Pressure

Implementation Method 2

the compressible piston is an object that changes volume of the object by a given volume when the object changes shape from a compressed configuration to an uncompressed configuration

Methodology Applied
Scientific EffectCompressibility: Compression

Data Source

PatentUS20260097165A1System for drug delivery with fixed dose size
Publication Date: 2026.04.09 MANTA MEDTECH LLC
  • US20260097165A1 patent drawing
  • US20260097165A1 patent drawing
  • US20260097165A1 patent drawing

AI summary

Embodiments relate to systems comprising Active Wearable Medical Device (AWMD) with an osmotic chamber containing or configured to receive an osmotic agent, a permeability module for fluid ingress, and a drug chamber holding a drug. A compressible piston, positioned between the chambers, moves longitudinally as a whole during operation. The compressible piston advances toward the drug chamber when a valve opens, enabling drug release through one or more outlets, and retracts when the valve closes, driven by osmotic pressure. A valve module regulates this flow. The system also comprises a fluid chamber containing fluid and a semipermeable membrane coupling it to the AWMD. A channel connected to the drug outlets delivers the drug externally.